Glycolytic enzymes can modulate cellular life span

Cancer Research

Volumn 65, Issue 1, 2005, Pages 177-185

  Kondoh, Hiroshi ^a,b   Lleonart, Matilde E ^a,e   Gil, Jesus ^a,b   Wang, Jing ^a   Degan, Paolo ^c   Peters, Gordon ^b   Martinez, Dolores ^a   Carnero, Amancio ^d   Beach, David ^a,f  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF GENOA   (Italy)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f Institute of Cell and Molecular Science   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE ISOMERASE; GLYCOLYTIC ENZYME; PHOSPHOGLYCERATE MUTASE; PROTEIN P53; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL AGING; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FIBROBLAST; GENE MUTATION; GENETIC SCREENING; GLYCOLYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE RAS; OXIDATIVE STRESS; PRIORITY JOURNAL; STEM CELL; WILD TYPE;

ANIMALS; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; EMBRYO; FIBROBLASTS; GENES, RAS; GLYCOLYSIS; MICE; MICE, INBRED C57BL; PHOSPHOGLYCERATE MUTASE;

EID: 11244347171     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999;24:68-72.
2. Warburg O. The metabolism of tumors. London: Constable: 1930.
3. 18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours. J Cancer Res Clin Oncol 2000;126:560-74.
4. Spaepen K, Stroobants S, Dupont P, et al. Early restaging positron emission tomography with (18) F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol 2002;13:1356-63.
5. Vesselle H, Schmidt RA, Pugsley JM, et al. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 2000;6:3837-44.
6. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961;25:585-621.
7. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol 2001;11:S27-31.
8. d'Adda di Fagagna F, Reaper PM, Clay Farrace L, et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003;426:194-8.
9. Smogorzewska A, de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J 2002;21:4338-48.
10. Serrano M, Blasco MA. Putting the stress on senescence. Curr Opin Cell Biol 2001;13:748-53.
11. Sherr CJ, DePinho RA. Cellular senescence: mitotic clock or culture shock? Cell 2000;102:407-10.
12. Itahana K, Zou Y, Itahana Y, et al. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol 2003;23:389-401.
13. Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, Campisi J. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol 2003;5:741-7.
14. Chen Q, Fischer A, Reagan JD, Yan LJ, Ames BN. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci U S A 1995;92:4337-41.
15. Lee AC, Fenster BE, Ito H, et al. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 1999;274:7936-40.
16. Brummelkamp TR, Bernards R. New tools for functional mammalian cancer genetics. Nat Rev Cancer 2003;3:781-9.
17. Harvey DM, Levine AJ. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev 1991;5:2375-85.
18. Trinei M, Giorgio M, Cicalese A, et al. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene 2002;21:3872-8.
19. Carnero A, Hudson JD, Price CM, Beach DH. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nat Cell Biol 2000;2:148-55.
20. Smith AG, Heath JK, Donaldson DD, et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988:336:688-90.
21. Hannon GJ, Sun P, Carnero A, et al. MaRX: an approach to genetics in mammalian cells. Science 1999;283:1129-30.
22. Kamijo T, Zindy F, Roussel MF, et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997;91:649-59.
23. Urbano AM, Gillham H, Groner Y, Brindle KM. Effects of overexpression of the liver subunit of 6-phosphofructo-1-kinase on the metabolism of a cultured mammalian cell line. Biochem J 2000;352 Pt 3:921-7.
24. Josse C, Legrand-Poels S, Piret B, Sluse F, Piette J. Impairment of the mitochondrial electron chain transport prevents NF-κB activation by hydrogen peroxide. Free Radic Biol Med 1998;25:104-12.
25. Beutler E. Glycolytic enzymes. Methods in haematology. New York, Churchill Livingstone 1986:57-72.
26. Degan P, Bonassi S, De Caterina M, et al. In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis 1995;16:735-41.
27. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 1999;190:1375-82.
28. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997;88:593-602.
29. Hinds PW, Finlay CA, Quartin RS, et al. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes. Cell Growth Differ 1990;1:571-80.
30. Tanaka N, Ishihara M, Kitagawa M, et al. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 1994;77:829-39.
31. Zhang J, Yu L, Fu Q, et al. Mouse phosphoglycerate mutase M and B isozymes: cDNA cloning, enzyme activity assay and mapping. Gene 2001;264:273-9.
32. Nairn J, Duncan D, Price NE, et al. Characterization of active-site mutants of Schizosaccharomyces pombe phosphoglycerate mutase. Elucidation of the roles of amino acids involved in substrate binding and catalysis. Eur J Biochem 2000;267:7065-74.
33. Rigden DJ, Alexeev D, Phillips SE, Fothergill-Gilmore LA. The 2.3 A X-ray crystal structure of S. cerevisiae phosphoglycerate mutase. J Mol Biol 1998;276:449-59.
34. Hue L, Feliu JE, Hers HG. Control of gluconeogenesis and of enzymes of glycogen metabolism in isolated rat hepatocytes. A parallel study of the effect of phenylephrine and of glucagon. Biochem J 1978;176:791-7.
35. Ng CC, Arakawa H, Fukuda S, Kondoh H, Nakamura Y. p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1. Oncogene 2003;22:4449-58.
36. Barak Y, Juven T, Haffner R, Oren M. mdm2 expression is induced by wild type p53 activity. EMBO J 1993;12:461-8.
37. Helbock HJ, Beckman KB, Ames BN. 8-Hydroxydeoxyguanosine and 8-hydroxyguanine as biomarkers of oxidative DNA damage. Methods Enzymol 1999;300:156-66.
38. Durany N, Joseph J, Campo E, Molina R, Carreras J. Phosphoglycerate mutase. 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas. Br J Cancer 1997;75:969-77.
39. Durany N, Joseph J, Jimenez OM, et al. Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma. Br J Cancer 2000;82:20-7.
40. 2 homeostasis by hypoxia-inducible factor 1 α. Genes Dev 1998;12:149-62.
41. Ruiz-Lozano P, Hixon ML, Wagner MW, et al. p53 is a transcriptional activator of the muscle-specific phosphoglycerate mutase gene and contributes in vivo to the control of its cardiac expression. Cell Growth Differ 1999;10:295-306.
42. Brand KA, Hermfisse U. Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J 1997;11:388-95.
43. Chen QM, Prowse KR, Tu VC, Purdom S, Linskens MH. Uncoupling the senescent phenotype from telomere shortening in hydrogen peroxide-treated fibroblasts. Exp Cell Res 2001;265:294-303.
44. Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev 1996;10:1054-72.
45. Wu Z, Earle J, Saito S, Anderson CW, Appella E, Xu Y. Mutation of mouse p53 Ser23 and the response to DNA damage. Mol Cell Biol 2002;22:2441-9.
46. Archer H, Bar-Sagi D. Ras and Rac as activators of reactive oxygen species (ROS). Methods Mol Biol 2002;189:67-73.
47. Irani K, Xia Y, Zweier JL, et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997;275:1649-52.
48. Shim H, Dolde C, Lewis BC, et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci U S A 1997;94:6658-63.
49. Fell DA, Thomas S. Physiological control of metabolic flux: the requirement for multisite modulation. Biochem J 1995;311:35-9.
50. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998;78:547-81.